10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $526,350 | +36.6% | 12,760 | +84.9% | 0.00% | – |
| Q2 2023 | $385,296 | -2.1% | 6,900 | -2.2% | 0.00% | – |
| Q1 2023 | $393,710 | -14.8% | 7,057 | -44.4% | 0.00% | – |
| Q4 2022 | $462,314 | +22.3% | 12,687 | -4.4% | 0.00% | – |
| Q3 2022 | $378,000 | -46.9% | 13,269 | -15.6% | 0.00% | – |
| Q2 2022 | $712,000 | -32.5% | 15,730 | +13.5% | 0.00% | -100.0% |
| Q1 2022 | $1,055,000 | -53.2% | 13,864 | -8.4% | 0.00% | 0.0% |
| Q4 2021 | $2,254,000 | +45.8% | 15,131 | +42.5% | 0.00% | 0.0% |
| Q3 2021 | $1,546,000 | +31.6% | 10,621 | +77.1% | 0.00% | 0.0% |
| Q2 2021 | $1,175,000 | +66.9% | 5,998 | +54.1% | 0.00% | – |
| Q1 2021 | $704,000 | +57.8% | 3,892 | +23.5% | 0.00% | – |
| Q4 2020 | $446,000 | +88.2% | 3,152 | +66.2% | 0.00% | – |
| Q3 2020 | $237,000 | – | 1,897 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |